• Profile
Close

LGALS3 promotes treatment resistance in glioblastoma and is associated with tumor risk and prognosis

Cancer Epidemiology, Biomarkers & Prevention Mar 28, 2019

Wang H, et al. - Researchers assessed how LGALS3 (which promotes tumor progression in several cancers) influences glioblastoma. Researchers observed effective protection of LGALS3 from ionizing irradiation or temozolomide-induced cell death in T98G and U251 cells. In addition, an independent risk factor for survival in patients with glioblastoma was reported to be possible with high expression of LGALS3. They observed an association of two SNP sites across the LGALS3 gene (rs4644 and rs4652) with increased risk for glioblastoma. They also found enhanced glioblastoma resistance to radio-chemotherapy (but not cell proliferation) due to the C allele of rs4652 and the A allele of rs4644.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay